KLRA Kailera Therapeutics, Inc.
Company Analysis
Latest News
🔴 Kailera Therapeutics is trading 5.2% down
Kailera Therapeutics is trading at $16.87, down 5.2% from a comparison close of $17.79 during regular trading. This is a price-action follow-up, so a separate...
🔴 Kailera Therapeutics, Inc. is trading 4.56% down
KLRA is trading at $18.42, down 4.56%.
🟢 Kailera Therapeutics is trading 5.2% up today as sentiment stabilizes after GLP-1 side effect concerns
Kailera Therapeutics is trading at $20.00 (5.2% up) today as the stock stages a modest recovery following two days of declines tied to GLP-1 side effect...
🔴 Kailera Therapeutics is trading 4.3% down today as GLP-1 side effect concerns and biotech weakness weigh on sentiment
Kailera Therapeutics is trading at $19.12 (-4.26%) as investors continue to focus on side effects from its oral GLP-1 obesity program. • The stock remains...
🔴 Kailera Therapeutics is trading 4.1% down today as GLP-1 side effect concerns persist
Kailera Therapeutics is trading 4.1% down today at $19.84 as investors continue to reassess Phase 3 data for its oral GLP-1 obesity pill, KAI-7535. •...
🔴 Kailera Therapeutics is trading 4% down today as side effect concerns weigh on Phase 3 GLP-1 data
Kailera Therapeutics is trading 4% down at $20.16 as investors reassess last week’s Phase 3 data for its oral GLP-1 agonist, KAI-7535. • While the stock...
🟢 Kailera Therapeutics Rises 4.7% Amid Re-evaluation of Positive Phase 3 Diabetes and Metabolic Data
Kailera Therapeutics is trading 4.7% up at $21.99 in pre-market. This positive movement follows the company's announcement on July 7, 2026, of positive topline...
🔴 KLRA is trading 4.5% down today on disappointing Phase 3 GLP-1 trial data
KLRA is trading 4.5% down at $21.25 as investors continue to react to mixed Phase 3 results for its oral GLP-1 candidate. • While the trial met primary...
🔴 KLRA makes sharp 10.5% drop
KLRA is trading at $20.86, down 10.5% versus the comparison close of $23.30 during regular trading. This is a price-movement alert; no separate...
🔴 KLRA is trading 5.8% down today despite announcing positive Phase 3 trial data for its obesity and diabetes drug.
KLRA is trading 5.8% down at $21.96 today, undergoing a pullback. This occurs despite Kailera Therapeutics announcing positive topline data from two Phase 3...
🟢 KLRA extends move to 5.3% up
KLRA is trading at $21.92, up 5.3% versus the comparison close of $20.82 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 KLRA extends move to 6.0% down
KLRA is trading at $20.70, down 6.0% versus the comparison close of $22.03 during regular trading. This is a price-movement alert; no separate company-specific...
Kailera Therapeutics joins Russell 3000E, scales leadership for obesity trials
Kailera Therapeutics, Inc. appointed Kathleen Tregoning as Chief Corporate Affairs Officer on June 29, 2026. CEO Ron Renaud stated Tregoning will support the...
🟢 KLRA extends move to 5.1% up
KLRA is trading at $21.89, up 5.1% versus the comparison close of $20.83 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 KLRA is trading 4.5% up today amid GLP-1 sector enthusiasm and post-IPO volatility
KLRA is trading 4.5% up today at $21.76 as the stock continues to experience post-IPO volatility alongside broader enthusiasm for the obesity and GLP-1 drug...
🔴 KLRA is trading 4% down today amid Q1 2026 earnings report
KLRA is trading 4% down today at $20.51 as the company is expected to report its Q1 2026 earnings today, June 25, 2026. • As a recently listed clinical-stage...
🟢 KLRA is trading 6% up today as it rebounds from a recent pullback
KLRA is trading at $22.65 (up 6%), rebounding from the prior session’s pullback and continuing its highly volatile post-IPO trading pattern. • The stock has...
🔴 KLRA extends move to 5.0% down
KLRA is trading at $21.73, down 5.0% versus the comparison close of $22.88 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 KLRA is trading 4.5% down today on profit-taking after recent rally
KLRA is trading 4.5% down at $21.86 on apparent profit-taking following a sharp multi-day rally. • The pullback follows significant gains of approximately 15%...
🟢 KLRA makes sharp 10.5% jump
KLRA is trading at $21.98, up 10.5% versus the comparison close of $19.90 during regular trading. This is a price-movement alert; no separate company-specific...